This webinar will explore the evolving landscape of B cell–targeting therapies in autoimmune diseases. Expert panelists will discuss key considerations in early-phase development, including:
- Drug delivery strategies
- Cohort selection
- Safety management
- Bioanalytical approaches
Designed for biotech sponsors, this discussion brings together scientific and clinical perspectives to help navigate complex trial designs and accelerate the path from discovery to development.
Panelists:
- Dr. Joel Weinthal, Executive Medical Director, Janux
- Prof. Sepehr Shakib, Consulting Medical Director, CMAX
- Dr. Carolyn Luscombe, Therapeutic Strategy Manager, Novotech
Moderator: Dr. Karen Scalzo-Inguanti, Director of Therapeutic Strategy, Novotech